Nurse Practitioner, Family · Franklin, KY
NPI
1366905242
Since 2019
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1112 S Main St
Franklin, KY, 42134
Phone (270) 598-9595
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
115,848 services
Medicare patients, 2024
348
Average age 74
Drug cost, 2024
$4.1M
1,535 prescriptions
Company payments, 2025
$4,015
From 55 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ayme J Rowland was code J1439 (injection, ferric carboxymaltose, 1 mg), 30,000 times for 24 patients. In total Ayme J Rowland billed 115,848 services in 119 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 30,000 | 24 | $0.87 | $26K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 12,240 | 15 | $0.28 | $3,424 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 7,600 | 13 | $44.22 | $336K |
| J0897 Injection, denosumab, 1 mg | Office | 3,360 | 21 | $18.81 | $63K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 3,000 | 16 | $0.11 | $330 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 1,715 | 12 | $6.41 | $11K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,500 | 15 | $14.96 | $22K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 680 | 28 | $0.09 | $61.28 |
| 99214 Office E&M - Established | Office | 544 | 219 | $75.20 | $41K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 310 | 169 | $10.28 | $3,187 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 290 | 19 | $0.62 | $181 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 280 | 11 | $0.25 | $70.53 |
| 96372 Injection Administration | Office | 271 | 83 | $8.26 | $2,237 |
| 96413 Chemotherapy Administration | Office | 166 | 63 | $74.37 | $12K |
| 96375 Injection Administration | Office | 159 | 41 | $9.39 | $1,493 |
By year: 2022 $540K for 39,904 services; 2023 $1.2M for 72,400 services; 2024 $1.5M for 115,848 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87086 Bacterial Culture | 15 | 12 | $7.91 | $119 |
Medicare prescription drug claims, 2024
In 2024, the drug Ayme J Rowland prescribed most often to Medicare patients was Acyclovir, with 99 prescriptions and refills. In total Ayme J Rowland wrote 1,535 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 99 | 117 | 31 | $1,247 |
| Letrozole Generic | 79 | 171 | 29 | $1,598 |
| Dexamethasone Generic | 77 | 79 | 29 | $1,312 |
| Prochlorperazine Maleate Generic | 70 | 72 | 54 | $1,220 |
| Ondansetron Odt Ondansetron | 62 | 63 | 50 | $2,990 |
| Potassium Chloride Generic | 59 | 79 | 23 | $782 |
| Olanzapine Generic | 55 | 55 | 20 | $96.71 |
| Ondansetron Hcl Generic | 53 | 57 | 27 | $2,749 |
| Levothyroxine Sodium Generic | 53 | 69 | 17 | $230 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 49 | 49 | 23 | $872 |
| Exemestane Generic | 43 | 79 | Under 11 | $6,083 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 43 | 44 | 19 | $97.98 |
| Methotrexate Methotrexate Sodium | 42 | 42 | Under 11 | $157 |
| Venclexta Venetoclax | 37 | 37 | Under 11 | $235K |
| Hydroxyurea Generic | 31 | 55 | Under 11 | $683 |
Brand drugs: - claims; generic drugs: 1,211 claims; opioid claims: 70.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ayme J Rowland $4,015 ($4,015 in general payments such as food, travel and fees) from 55 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $291.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 11 | $291 |
| Pfizer Inc. PFE | 15 | $285 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $229 |
| Janssen Biotech, Inc. JNJ | 8 | $224 |
| Gilead Sciences, Inc. GILD | 6 | $205 |
| Genzyme Corporation SNY | 6 | $180 |
| Seagen Inc. PFE | 2 | $178 |
| Daiichi Sankyo Inc. 4568.T | 5 | $137 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $124 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.